glp-1 parch Do Patches Work? No — Here's Why Kind Patches GLP 1 Patches
Description
[(accessed on 18 May 2025)]
Semaglutide (Ozempic, Wegovy) administered once weekly demonstrates injection site reaction rates of 1.2-1.4% according to FDA prescribing information
According to researchers from the University of Pennsylvania and Cedars-Sinai Medical Center, the number of non-diabetic patients starting these medications jumped from 21,000 in 2019 to over 174,000 in 2023
Most data comes from other GLP-1 receptor agonists, not tirzepatide specifically, and cannot establish causation or support clinical use for addiction at this time
We screened 3681 patients who underwent PCI from January 2020 to March 2024 and enrolled 1796 patients with T2D
